
    
      The study is a Comparative Clinical and Biochemical Study Evaluating the effect of Proton
      Pump Inhibitors versus histamine 2 Receptor antagonists as an adjuvant with chemotherapy in
      patients with Non-hodgkin Lymphoma to compare the difference in efficacy.
    
  